CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | Walker Neal President and CEO | Grant or award · Restricted stock units | +52,564 | 52,564 | ||
| 2020-03-02 | Walker Neal President and CEO | Option exercise · Restricted stock units | −52,564 | 0 | ||
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Option exercise | +25,750 | 195,117 | ||
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −7,162 | $1.26 | $9K | 187,955 |
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −25,750 | 77,250 | ||
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +116,160 | 116,160 | ||
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +66,377 | 66,377 | ||
| 2020-03-02 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +33,189 | 33,189 | ||
| 2020-03-02 | SCHIFF ANDREW N Director | Option exercise | +8,876 | 8,876 | ||
| 2020-03-02 | SCHIFF ANDREW N Director | Grant or award · Restricted stock units | +8,876 | 8,876 | ||
| 2020-03-02 | SCHIFF ANDREW N Director | Option exercise · Restricted stock units | −8,876 | 0 | ||
| 2020-03-02 | Reasons Bryan M. Director | Option exercise | +8,876 | 8,876 | ||
| 2020-03-02 | Reasons Bryan M. Director | Grant or award · Restricted stock units | +8,876 | 8,876 | ||
| 2020-03-02 | Reasons Bryan M. Director | Option exercise · Restricted stock units | −8,876 | 0 | ||
| 2020-03-02 | Powell Andrew Kenneth William Director | Option exercise | +8,876 | 9,376 | ||
| 2020-03-02 | Powell Andrew Kenneth William Director | Grant or award · Restricted stock units | +8,876 | 8,876 | ||
| 2020-03-02 | Powell Andrew Kenneth William Director | Option exercise · Restricted stock units | −8,876 | 0 | ||
| 2020-03-02 | Molineaux Christopher P. Director | Option exercise | +8,876 | 16,558 | ||
| 2020-03-02 | Molineaux Christopher P. Director | Grant or award · Restricted stock units | +8,876 | 8,876 | ||
| 2020-03-02 | Molineaux Christopher P. Director | Option exercise · Restricted stock units | −8,876 | 0 |
Page 37 of 47 · 928 trades